- May 28, 2021
Industry News: Ori Biotech and Vineti have formed strategic partnership to deliver integrated manufacturing and supply chain solutions for cell and gene therapies
Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply…
- May 26, 2021
Ori Biotech and Vineti collaborate on digital platform for CGTs
Ori Biotech and Vineti are partnering to produce an integrated solution to streamline the manufacture and delivery of cell and gene therapies (CGTs).
Ori provides…
- April 20, 2021
McKesson Ventures highlights investment priorities amidst a trail of successful exits
McKesson Ventures is one of the most active investors in the biopharma software sector with Vineti, Komodo Health, Evidation and M2Gen among its portfolio companies.…
- April 1, 2021
Six Cell and Gene Therapy Commercialization Trends
Amy DuRoss, CEO and Co-founder, Vineti and Keith Martino, VP/General Manager, Biopharma Services, Cardinal Health Specialty Solutions discuss what to watch in the next 12…
- March 24, 2021
Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) -- A broad coalition of biopharmaceutical and technology leaders today announced a new strategic collaboration to promote new…
- March 24, 2021
Exclusive: An industry consortium wants to standardize cell tracking for regenerative meds. Could that avert a disaster?
In the fast-moving world of regenerative medicine, the open secret among industry experts is that manufacturing is exceedingly difficult and will take a Herculean effort…
- March 15, 2021
Software for the cell and gene therapy wave: Vineti’s Amy DuRoss on The Long Run
- February 17, 2021
How to Evolve and Mature Tech for Biotech and Pharma
In the third part of our three series podcast with Vineti, Chief Technology Officer Phil Calvin speaks about the technology that most excites him and…
- January 13, 2021
Lessons Learned: What to Know About Producing Personalized Therapies
In the second of our three-series podcast with Vineti, Chief Commercial Officer Joe DePinto provides a first-hand look at what it takes to actually produce…
- January 11, 2021
Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require
SAN FRANCISCO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new suite…
- January 7, 2021
Vineti, a management platform for personalized treatments such as cell and gene therapy
- December 15, 2020
Industrializing Personalized Therapeutics: Can You Really “Mass Customize” Patient-specific Pharmaceuticals?
In the first of a three-series podcast with Vineti, CEO and Founder Amy DuRoss discusses the rapid growth of cell and gene therapies and whether…
We use cookies for analytics, marketing purposes, and to improve our site. You agree to our use of cookies by clicking yes. To find out more, including how to change your settings, see our privacy policy for details.